您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Apelin-13
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Apelin-13
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Apelin-13图片
CAS NO:217082-58-1
包装与价格:
包装价格(元)
100mg电议
250mg电议
500mg电议

产品介绍
Apelin-13 是G 蛋白偶联受体angiotensin II protein J (APJ)的内源性配体,激活G蛋白偶联受体的EC50值为 0.37 nM。Apelin-13 广泛分布于中枢和外周神经系统。Apelin-13 具有扩张血管和降压作用。Apelin-13 也可用于 2 型糖尿病综合征的研究。
生物活性

Apelin-13 is an endogenous ligand for theG-protein coupled receptor angiotensin II protein J (APJ), activating this G protein-coupled receptor with anEC50value of 0.37 nM. Apelin-13 is widely distributed in the central and peripheral nervous systems. Apelin-13 has vasodilatory and antihypertensive effects. Apelin-13 also can be used for researching type 2 diabetes and metabolic syndrome[1][2][3].

IC50& Target

IC50: 0.37 nM (APJ)[1]

体内研究
(In Vivo)

Apelin-13 (200 μg/kg; IP, daily for 4 weeks) improves cardiac function, improves insulin resistance, improves lipid metabolism, significantly decreases TNF-α and leptin on serum, induces the expression of Apelin-12 in serum and markedly elevates GLUT4 and p-AMPKα2 levels[2].
Apelin-13 (10 and 100 μM; ICV, single dosage) increases the spontaneous discharges in the majority of pallidal neurons[4].

Animal Model:Goto-Kakizaki (GK) rats (12 weeks old; 240-280 g; fed with a high-fat diet: 66.5% standard chow, 10% lard, 20% sucrose, 2.5% cholesterol and 1% pig bile salt)[2]
Dosage:200 μg/kg
Administration:IP, daily for 4 weeks
Result:Significantly decreased heart rate; lowered the levels of fasting plasma glucose (FPG), fasting insulin (FINS) and homeostasis model assessment for insulin resistancey (HOMA-IR); decreased serum levels of total cholesterol (TC), triglyceride (TG) and low density lipoprotein-cholesterol (LDL-C) and increased high density lipoprotein-cholesterol (HDL-C); decreased NO level, cNOS activity, TNF-α and leptin in serum; induced the expression of Apelin-12.
Animal Model:Adult Wistar rats (SPF, 8-10 weeks, 240-280 g)[4]
Dosage:10 and100 μM
Administration:ICV, single dosage
Result:Increased the spontaneous discharges in the majority of pallidal neurons.
Clinical Trial
分子量

1550.83

Formula

C69H111N23O16S

CAS 号

217082-58-1

Sequence

Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe

Sequence Shortening

QRPRLSHKGPMPF

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.